logo
Select company
Select metric
-598.4%EBIT Margin
VS
Market
7
Sector
23
Industry
41
History
-
$ 9.03Close
$ 1.1 - $ 9.52 52-Week Range
Ticker Information

Ticker

TNGX

Company Name

TANGO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TANGO THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TNGX - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -145.39M-598.4%$ 24.3M
3/31/2025$ -132.06M-322.17%$ 40.99M
12/31/2024$ -130.09M-309.24%$ 42.07M
9/30/2024$ -123.19M-283.95%$ 43.38M
6/30/2024$ -116.32M-273.63%$ 42.51M
3/31/2024$ -111.48M-299.41%$ 37.23M
12/31/2023$ -101.61M-278.18%$ 36.53M
9/30/2023$ -99.9M-266.36%$ 37.51M
6/30/2023$ -106.71M-316.7%$ 33.7M
3/31/2023$ -110.92M-446.04%$ 24.87M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TANGO THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, TANGO THERAPEUTICS INC's average EBIT % has been -324.33%.
  • The median EBIT % for TANGO THERAPEUTICS INC during this period was -304.32%
  • TANGO THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -156.43%.
  • The lowest EBIT % recorded by TANGO THERAPEUTICS INC in the same timeframe -598.4%

TANGO THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
VIR : VIR BIOTECHNOLOGY INC -2894.48%QURE : UNIQURE NV -942.05%NUVB : NUVATION BIO INC -1408.67%AUTL : AUTOLUS THERAPEUTICS PLC -803.46%ABUS : ARBUTUS BIOPHARMA CORP -351.17%ZBIO : ZENAS BIOPHARMA INC -1178.41%BCYC : BICYCLE THERAPEUTICS PLC -1286.34%ALMS : ALUMIS INC -1177.16%FHTX : FOGHORN THERAPEUTICS INC -311.9%IMNM : IMMUNOME INC -1687.08%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for TANGO THERAPEUTICS INC is calculated as follows: EBIT [ $ -116.18K ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

TNGX - EBIT Margin, Last 5 years

-598.4%

Minimum

Jun 30, 2025

-156.43%

Maximum

Dec 31, 2021

-324.33%

Average

-304.32%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%